Safety and Efficacy of Different Antithrombotic Strategies after Transcatheter Aortic Valve Implantation: A Network Meta-Analysis.
Eliano Pio NavareseLeonardo GrisafiEnrico Guido SpinoniMarco Giovanni MennuniAndrea RognoniJakub RatajczakPrzemysław PodhajskiEndrin KoniJacek KubicaGiuseppe PattiPublished in: Thrombosis and haemostasis (2021)
The present network meta-analysis supports after TAVI the use of SAPT in patients without indication for OAC and OAC alone in those needing long-term anticoagulation.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- ejection fraction
- aortic valve
- aortic valve replacement
- systematic review
- end stage renal disease
- atrial fibrillation
- chronic kidney disease
- newly diagnosed
- transcatheter aortic valve replacement
- prognostic factors
- venous thromboembolism
- randomized controlled trial
- peritoneal dialysis
- coronary artery disease